Dr Tabea Sutter
Treatment regimens in patients over 64 years with acute myeloid leukaemia: a retrospective single-institution, multi-site analysis.
Sutter T, Schittenhelm M, Volken T, Lehmann T. Treatment regimens in patients over 64 years with acute myeloid leukaemia: a retrospective single-institution, multi-site analysis. Hematology 2023; 28:2206694.
May 11, 2023Treatment regimens in patients over 64 years with acute myeloid leukaemia: a retrospective single-institution, multi-site analysis.
May 11, 2023Hematology 2023; 28:2206694
Sutter Tabea, Schittenhelm Marcus, Volken Thomas, Lehmann Thomas
HIV protease inhibitors for the treatment of multiple myeloma.
Mendez Lopez M, Sutter T, Driessen C, Besse L. HIV protease inhibitors for the treatment of multiple myeloma. Clin Adv Hematol Oncol 2019; 17:615-623.
Nov 1, 2019HIV protease inhibitors for the treatment of multiple myeloma.
Nov 1, 2019Clin Adv Hematol Oncol 2019; 17:615-623
Mendez Lopez Max, Sutter Tabea, Driessen Christoph, Besse Lenka
Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis
Filli L, Weller M, Petersen J, Philipp G, Killeen T, Sutter T, Weller D, Lorincz L, Reuter K, Kapitza S, Zörner B, Linnebank M. Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis. Neurology 2017; February
Feb 2, 2017Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis
Feb 2, 2017Neurology 2017; February
Filli Linard, Weller Michael, Petersen Jens, Philipp Gruber, Killeen Tim, Sutter Tabea, Weller David, Lorincz Lilla, Reuter Katja, Kapitza Sandra, Zörner Björn, Linnebank Michael